Home › Trial NCT00970502
Erlotinib, Celecoxib and Reirradiation for Recurrent Head and Neck Cancer
- Trial IDNCT00970502
- StatusCompleted
- PhasePhase 1/2
- Study typeInterventional
- SponsorJohnny Kao
- Enrollment15
- Start date2007-02
- ConditionsCancer of the Pharynx · Cancer of the Larynx · Cancer of the Neck · Paranasal Sinus Neoplasms · Cancer of the Head
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.